Daejeon, South Korea

Hongmarn Park

This inventor holds 2 USPTO granted patents. Top assignee: Korea Advanced Institute of Science and Technology. Active years: 2017-2019.


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2017-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Hongmarn Park

Introduction

Hongmarn Park is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of artificial nucleic acids. With a total of 2 patents, his work focuses on innovative methods for gene silencing and the creation of expression libraries.

Latest Patents

Hongmarn Park's latest patents include two groundbreaking inventions. The first is titled "Genome-originated artificial ncRNA expression library and method of preparing the same." This invention relates to an artificial ncRNA expression library that secures the stability of the artificial ncRNA by cloning random fragmented DNA. The method involves using a double stem-loop RNA scaffold to enhance the stability of the ncRNA.

The second patent is "Effective method for specific gene silencing using artificial small RNA." This invention describes a nucleic acid molecule with a stem-loop structure that interacts with a target nucleic acid for effective gene silencing in prokaryotes. The composition includes a nucleic acid complex that maintains the single-strandedness of the target recognition sequence, facilitating efficient gene silencing.

Career Highlights

Hongmarn Park is affiliated with the Korea Advanced Institute of Science and Technology, where he continues to advance his research in biotechnology. His work has garnered attention for its potential applications in genetic engineering and therapeutic development.

Collaborations

Some of his notable coworkers include Younghoon Lee and Geunu Bak, who have collaborated with him on various research projects.

Conclusion

Hongmarn Park's innovative contributions to biotechnology, particularly in artificial nucleic acids and gene silencing, highlight his role as a leading inventor in his field. His patents reflect a commitment to advancing scientific knowledge and practical applications in genetic research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…